Because the health care system has become more cost-conscious, and bec
ause professional organizations vary in their recommendations for wome
n's health maintenance, it is more important than ever to use an evide
nce-based approach for selecting health maintenance interventions wise
ly. The Papanicolaou smear is a gold standard for cancer screening if
women undergo regular testing; however, data conflict on how often wom
en should be screened and how risk factors for cervical cancer should
be interpreted. Postmenopausal estrogen replacement therapy slows oste
oporotic bone loss and may decrease a woman's relative risk of coronar
y artery disease. The relationship of hormone replacement therapy (est
rogen plus progestin) to the risk of breast cancer still remains uncle
ar. Although new data suggest that screening mammography may reduce br
east cancer mortality by 20 percent or more in women over 40 years of
age, its use in women who are 40 to 49 years of age is still controver
sial. Family physicians, as advocates for women's health, are ideally
positioned for leadership roles in the policy making that may ultimate
ly find solutions to these controversial issues.